pmc logo image
Logo of jclinpathJournal of Clinical PathologyCurrent TOCInstructions for authors

Formats:

J Clin Pathol. 1998 March; 51(3): 257–258.
PMCID: PMC500655
Value of assessing parathyroid hormone-like activity in a case of extreme hypercalcaemia.
L Ranganath, H Jamal, L Jones, and P F Goddard
Department of Chemical Pathology, Epsom General Hospital, UK.
Abstract
A previously well 70 year old woman was admitted to hospital following a three day history of vomiting and confusion. Her serum calcium was 6.58 mmol/l, phosphate 1.09 mmol/l, and alkaline phosphatase 91 iu/l. The mechanism of this hypercalcaemia was not obvious as there was no evidence of a primary malignancy, lymphadenopathy or hepatosplenomegaly. The calculation of indices of urinary excretion of calcium and phosphate suggested the presence of excessive parathyroid hormone (PTH) activity as the mechanism of hypercalcaemia. Plasma intact PTH, 25-hydroxycholecalciferol, and 1,25-dihydroxycholecalciferol were not raised suggesting the presence of PTH related peptide (rP). This led to a systematic search for a malignancy, which revealed the presence of a high grade B cell non-Hodgkin's lymphoma confined to the bone marrow. Plasma PTH-rP was subsequently shown to be raised confirming the interpretation of the initial urinary and calcium excretion indices. This case highlights the value of standard laboratory measurements such as urinary calcium and phosphate excretion in cases of hypercalcaemia of obscure aetiology, which can complement measurements of PTH and other calcitropic hormones.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (379K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
 
 
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
  • Fisken RA, Heath DA, Somers S, Bold AM. Hypercalcaemia in hospital patients. Clinical and diagnostic aspects. Lancet. 1981 Jan 24;1(8213):202–207. [PubMed]
  • Marcus R. Laboratory diagnosis of primary hyperparathyroidism. Endocrinol Metab Clin North Am. 1989 Sep;18(3):647–658. [PubMed]
  • Davies SV, Vora J, Wardrop CA. Parathyroid hormone related protein (PTHrP) in hypercalcaemia of lymphoproliferative disease. J Clin Pathol. 1993 Feb;46(2):188–188. [PubMed]
  • Firkin F, Seymour JF, Watson AM, Grill V, Martin TJ. Parathyroid hormone-related protein in hypercalcaemia associated with haematological malignancy. Br J Haematol. 1996 Sep;94(3):486–492. [PubMed]
  • Kremer R, Shustik C, Tabak T, Papavasiliou V, Goltzman D. Parathyroid-hormone-related peptide in hematologic malignancies. Am J Med. 1996 Apr;100(4):406–411. [PubMed]